SCHEMBL29408449

SCHEMBL29408449

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(C)=O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)NCC(=O)O

nearest known ligand 0.65

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 4/20 0.61
▸ CALCR P30988 4/20 0.60
▸ TFPI P10646 4/20 0.60
▸ C5AR1 P21730 1/20 0.58
▸ NPY2R P49146 6/20 0.58
▸ NPY4R P50391 6/20 0.58
▸ NPY5R Q15761 6/20 0.58
▸ NPY1R P25929 4/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29408452 1.00 F2 (0.61) F2CALCRTFPIC5AR1NPY2R
SCHEMBL30974242 0.91 CALCR (0.62) F2CALCRNPY2RNPY4RNPY5R
SCHEMBL31005061 0.91 CALCR (0.62) F2CALCRNPY2RNPY4RNPY5R
SCHEMBL30495635 0.88 NPY2R (0.66) F2CALCRNPY2RNPY4RNPY5R
SCHEMBL30495758 0.88 CALCR (0.72) F2CALCRTFPINPY2RNPY4R
SCHEMBL8816036 0.88 CALCR (0.75) F2CALCRTFPINPY2RNPY4R
SCHEMBL29812377 0.88 CALCR (0.60) F2CALCR
SCHEMBL30200345 0.88 CALCR (0.69) F2CALCRNPY2RNPY4RNPY5R
SCHEMBL30432035 0.87 NPY2R (0.59) F2CALCRNPY2RNPY4RNPY5R
SCHEMBL29767747 0.87 CALCR (0.64) F2CALCRC5AR1NPY2RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113493762-B Method for enhancing plant immune effect and application thereof 中国科学院分子植物科学卓越创新中心 2023-12-19 — — CN claimed
CN-116178461-A Cyclized phosphate sugar ester compound and application thereof 中国农业大学 2023-05-30 — — CN claimed
US-20230036503-A1 Fusion Protein, Amino Acid Sequence Thereof, Coding Nucleotide Sequence Thereof, Preparation Method Thereof and Use Thereof SICHUAN AGRICULTURAL UNIVERSITY (CN) 2023-02-02 — — US claimed
US-12599649-B2 Bioactive polypeptides for improvements in plant protection, growth and productivity SPOGEN BIOTECH INC. (US) 2026-04-14 — — US disclosed
EP-4704577-A1 CUTIN COMPOSITIONS FOR TREATMENT OF PLANT DISEASE Universidade Nova de Lisboa (PT) 2026-03-11 — — EP disclosed
US-12534700-B2 Beneficial microbes for delivery of effector peptides or proteins and use thereof PI AGSCIENCES, INC. (US) 2026-01-27 — — US disclosed
US-20250338808-A1 COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY IN PLANTS BOYCE THOMPSON INSTITUTE FOR PLANT RES INC (US) 2025-11-06 — — US disclosed
US-20250324980-A1 COMPOSITIONS FOR DELIVERY OF AGENTS INTO PLANT CELLS OHIO STATE INNOVATION FOUNDATION (US) 2025-10-23 — — US disclosed
US-12382888-B2 Compositions and methods for modulating immunity in plants BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (US) 2025-08-12 — — US disclosed
US-20250241982-A1 BIOACTIVE POLYPEPTIDES FOR IMPROVEMENTS IN PLANT PROTECTION, GROWTH AND PRODUCTIVITY SPOGEN BIOTECH INC. 2025-07-31 — — US disclosed
US-20250163450-A1 IRON MAN (IMA) OVEREXPRESSION INCREASES DISEASE RESISTANCE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2025-05-22 — — US disclosed
US-20220241765-A1 NOVEL ARTIFICIAL PROTEIN CATALYST GLYTECH, INC. (JP) 2022-08-04 — — US disclosed
CN-112280790-B Application of rice receptor protein-like coding gene OsRLP1 in resisting rice black-streaked dwarf virus 宁波大学 2022-07-01 — — CN disclosed
US-11371011-B2 Beneficial microbes for delivery of effector peptides or proteins and use thereof PLANT HEALTH CARE, INC. (US) 2022-06-28 — — US disclosed
CN-113249395-B Application of soybean agglutinin receptor kinase Rsc7-1 coding gene 南京农业大学 2022-04-29 — — CN disclosed
EP-3978023-A1 NOVEL ARTIFICIAL PROTEIN CATALYST Glytech, Inc. (JP) 2022-04-06 — — EP disclosed
US-11292819-B2 Engineering pathogen resistance in plants THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-04-05 — — US disclosed
US-20220087268-A1 BIOACTIVE POLYPEPTIDES FOR IMPROVEMENTS IN PLANT PROTECTION, GROWTH AND PRODUCTIVITY GENISYS CREDIT UNION 2022-03-24 — — US disclosed
CN-114206388-A Novel artificial protein catalysts 株式会社糖锁工学研究所 2022-03-18 — — CN disclosed
US-20220064661-A1 AGRICULTURAL COMPOSITIONS AND RELATED METHODS FLAGSHIP PIONEERING INNOVATIONS VI, LLC 2022-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220241765-A1 NOVEL ARTIFICIAL PROTEIN CATALYST MAX, MMEL1, CHLSN F2 768/4885CALCR 2923/4885TFPI 3685/4885
US-20250241982-A1 BIOACTIVE POLYPEPTIDES FOR IMPROVEMENTS IN PLANT PROTECTION, GROWTH AND PRODUCTIVITY GHITM, VIP, MAX F2 2880/4885CALCR 2113/4885TFPI 3404/4885
US-12599649-B2 Bioactive polypeptides for improvements in plant protection, growth and productivity MAX, VIP, MRTO4 F2 2127/4885CALCR 3285/4885TFPI 3608/4885
US-20250324980-A1 COMPOSITIONS FOR DELIVERY OF AGENTS INTO PLANT CELLS ARGLU1, PHAX, VMA21 F2 4522/4885CALCR 4767/4885TFPI 4611/4885
US-20250338808-A1 COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY IN PLANTS SLC11A2, IFNG, STING1 F2 3719/4885CALCR 3624/4885TFPI 4346/4885
US-12382888-B2 Compositions and methods for modulating immunity in plants SLC11A2, IFNG, STING1 F2 3719/4885CALCR 3624/4885TFPI 4346/4885
US-12534700-B2 Beneficial microbes for delivery of effector peptides or proteins and use thereof GLUL, MLX, GDA F2 3209/4885CALCR 3937/4885TFPI 3974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback